Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
ANI Pharmaceuticals | 1,422 | 2023q3 | |||||||||
AbbVie | 315,227 | 2023 | |||||||||
Amarin Corporation | 351 | 2023q2 | |||||||||
Anika Therapeutics | 309 | 2023q3 | |||||||||
AstraZeneca | 209,961 | 2023q2 | |||||||||
Aurinia Pharmaceuticals | 704 | 2021 | |||||||||
Aurora Cannabis | 967 | 2022q2 | |||||||||
Axsome Therapeutics | 2,954 | 2023q3 | |||||||||
Aytu BioPharma | 10 | 2022 | |||||||||
Bausch Health | 3,493 | 2023 | |||||||||
Bayer | 28,003 | 2022 | |||||||||
Beyond Air | 50 | 2024q1 | |||||||||
Bolt Biotherapeutics | 46 | 2023q3 | |||||||||
Bristol-Myers Squibb | 105,665 | 2023q3 | |||||||||
CSPC Pharmaceutical | 14,588 | 2022q3 | |||||||||
CV Sciences | 4 | 2021 | |||||||||
CanSino Biologics | 246 | 2022 | |||||||||
Canopy Growth | 702 | 2024q3 | |||||||||
Cipla | 14,464 | 2022 | |||||||||
Citius Pharmaceuticals | 125 | 2023q3 |